HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anti-arrhythmic effect of the sigma-receptor blocker DuP 734 in ischemia and myocardial reperfusion].

Abstract
It has been found that in vivo pretreatment of rats with the sigma receptor antagonist DuP 734 (1 mg/kg) resulted in an increase in the heart tolerance to ischemic and reperfusion arrhythmias both in vivo and ex vivo. Administration of DuP 734 (1 mg/liter) directly in the perfusion solution of isolated rat heart 10 min before total ischemia also promoted a decrease in the incidence of reperfusion arrhythmias. The normoxic perfusion of isolated rat heart at a dose of 1 mg/liter had no effect on the action potential. It was concluded that antiarrhythmic effect of DuP 734 might depend on the decrease in the Ca2+ overload but not on K+ and Na+ channel blockade.
AuthorsIu B Lishmanov, L N Maslov, A V Krylatov, S A Afanas'ev, V Iu Timofeev, P Gilligan, S V Tam
JournalEksperimental'naia i klinicheskaia farmakologiia (Eksp Klin Farmakol) 2000 Nov-Dec Vol. 63 Issue 6 Pg. 24-7 ISSN: 0869-2092 [Print] Russia (Federation)
Vernacular TitleIssledovanie antiaritmicheskoĭ aktivnosti blokatora sigma-retseptorov DuP 734 v usloviiakh ishemii i reperfuzii miokarda.
PMID11202505 (Publication Type: Journal Article)
Chemical References
  • Anti-Arrhythmia Agents
  • Narcotic Antagonists
  • Piperidines
  • Receptors, sigma
  • DuP 734
Topics
  • Action Potentials
  • Animals
  • Anti-Arrhythmia Agents (pharmacology)
  • Arrhythmias, Cardiac (etiology, physiopathology, prevention & control)
  • Arterial Occlusive Diseases (complications)
  • Coronary Disease (complications)
  • Electrocardiography
  • In Vitro Techniques
  • Microelectrodes
  • Myocardial Infarction (etiology, pathology)
  • Myocardial Reperfusion Injury (etiology, physiopathology, prevention & control)
  • Myocardium (metabolism, pathology)
  • Narcotic Antagonists (pharmacology)
  • Piperidines (pharmacology)
  • Rats
  • Rats, Wistar
  • Receptors, sigma (antagonists & inhibitors, metabolism)
  • Sclerosis (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: